| Study | Treatment 1 | Treatment 2 | RR | 95% CI lower limit | 95% CI upper limit |
| Abril‐Molina 2021 | Levosimendan | Placebo | 0.5445 | 0.0436 | 6.7964 |
| Cavigelli‐Brunner 2018 | Dobutamine | Milrinone | 0.9245 | 0.0191 | 44.8254 |
| Costello 2014 | Milrinone | Placebo | 0.4536 | 0.0322 | 6.3865 |
| Momeni 2011 | Levosimendan | Milrinone | 1.2005 | 0.2206 | 6.5335 |
| Pellicer 2013 | Levosimendan | Milrinone | 1.2005 | 0.2206 | 6.5335 |
| Thorlacius 2020 | Levosimendan | Milrinone | 1.2005 | 0.2206 | 6.5335 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.